Central obesity and dietary intake in HIV/AIDS patients

Revista de Saude Publica

Volumn 40, Issue 4, 2006, Pages 634-640

  Jaime, Patrícia ^a   Florindo, Alex Antonio ^a   Latorre, Maria do Rosário Dias de Oliveira ^a   Segurado, Aluísio Augusto Cotrim ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anti HIV agents, adverse effects; Cross sectional studies; Dietary fats; Food consumption; HIV associated lipodystrophy syndrome; Obesity; Waist hip ratio

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ABDOMINAL FAT; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BODY MASS; BRAZIL; CARBOHYDRATE DIET; EPIDEMIOLOGY; FAT INTAKE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; METABOLISM; MIDDLE AGED; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; SOCIOECONOMICS; WAIST HIP RATIO;

ABDOMINAL FAT; ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BODY MASS INDEX; BRAZIL; DIETARY CARBOHYDRATES; DIETARY FATS; EPIDEMIOLOGIC METHODS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; OBESITY; SOCIOECONOMIC FACTORS; WAIST-HIP RATIO;

EID: 33947110000     PISSN: 00348910     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0034-89102006000500012     Document Type: Article

References (22)

1. Batterham MJ, Garsia R, Greenop PA. Dietary intake, serum lipids, insulin resistance and body composition in the era of highly active antiretroviral therapy 'Diet FRS Study'. Aids. 2000;14:1839-43.
2. Carr A, Samaras K, Thorisdottir A, Kaufmann GR, Chisholm DJ, Cooper DA. Diagnosis, prediction, and natural course of HIV-1 protease inhibitor associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet. 1999;353:2093-9.
3. Chen D, Misra A, Gang A. Lipodystrophy in human immunodeficiency virus-infected patients. J Clin Endocrinol Metab. 2002;87:4845-56.
4. Florindo AA, Latorre MRDO, Santos FCM, Borelli A, Rocha MS, Segurado AAC. Validação de métodos de estimativa de gordura corporal em portadores do HIV/Aids, Rev Saúde Pública. 2004;38:643-9.
5. Florindo AA, Latorre MRDO, Santos ECM, Negrao CE, Azevedo LF, Segurado AAC. Validity and reliability of the Baecke questionnaire for the evaluation of habitual physical activity among people living with HIV/ Aids. Cad Saúde Pública. 2006;22:535-41.
6. Galli M, Polo R, Saint-Marc, Walli R. Guidelines to describe morphologic and metabolic alterations (MMA) under ART: the Marrakech Classification. Nutr Metab Disord HIV Infect. 2002;1:25-9.
7. Gervasoni C, Ridolfo AL, Trifiro G, Santambrogio S, Norbiato G, Musicco M, et al. Redistribution of body fat in HIV-infected women undergoing combined antiretroviral treatment. Aids, 1999;13:465-71.
8. Goris AHC, Westerterp KR. Improved reporting of habitual food intake after confrontation with earlier results on food reporting. Br J Nutr. 2000;83:363-9.
9. Hadigan C, Jeste S, Anderson EJ, Tsay R, Cyr H, Grinspoon S. Modifiable dietary habits and their relation to metabolic abnormalities in men and women with human immunodeficiency virus infection and fat redistribution. Clin Infect Dis. 2001;33:710-7.
10. Hadigan C, Meigs JB, Corcoran C, Rietschel P, Piecuch S, Basgoz N, et al. Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin Infect Dis. 2001;32:130-9.
11. Hendricks KM, Dong KR, Tang AM, Ding B, Spiegelman D, Woods MN, et al. High-fiber diet in HIV-positive men is associated with lower risk of developing fat deposition. Am J Clin Nutr. 2003;78:790-5.
12. Kotler D, Rosenbaum K, Wang J, Pierson RN. Studies of body composition and fat distribution in HIV-infected and control subjects. J Acquir Immune Defic Syndr Hum Retrovirol. 1999;20:228-37.
13. Marins JRP, Jamal LF, Chen SY, Barros MBA, Hudes ES, Barbosa AA, et al, Dramatic improvement in survival among adult Brazilian AIDS patients. Aids. 2003;17:1675-82.
14. Martinez E, Mocroft A, Garcia-Viejo MA, Pérez-Cuevas JB, Blanco JL, Mallolas J, et al. Risk of lipodystrophy in HIV-1 infected patients treated with protease inhibitors: a prospective cohort study. Lancet. 2001;357:592-8.
15. National Heart, Lung, and Blood Institute; National Institutes of Diabetes and Digestive and Kidney Diseases. Clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults. Bethesda: National Institutes of Health, 1998. (NHI Publication 4083).
16. Shevitz A, Wanke C, Falutz J, Kotler D. Clinical perspectives on HIV-associated lipodystrophy syndrome: an update. Aids. 2001;15:1917-30.
17. Shevitz AH, Knox TA. Nutrition in the era of highly active antiretroviral therapy. Clin Infect Dis. 2001;32:1769-75.
18. Sichieri R, Everhart JE. Validity of a Brazilian food frequency questionnaire against dietary recalls and estimated energy intake. Nutr Res. 1998;18:1649-59.
19. Vella S. Future treatment perspectives. J Acquir Immune Defic Syndr. 2003;34(Suppl 1):95-100.
20. Willett W, Stampfer M. Implications of total energy intake for epidemiologic analyses. In: Willett W. Nutritional epidemiology. 2nd ed. New York: Oxford University Press; 1998. p. 273-301.
21. World Health Organization - WHO. Obesity: preventing and managing the global epidemic. Report, Geneva; 2000. [WHO Technical Report Series, 894]
22. World Health Organization - WHO. Diet, nutrition and the prevention of chronic diseases. Report. Geneva; 2003. [WHO Technical Report Series, 916]